DexCom raises 2026 revenue guidance midpoint DexCom posted Q2 financial results that beat expectations, driven by strong sales of its continuous glucose monitors. The company now expects 2026 revenue of $5.18B-$5.25B, up from its previous forecast. DexCom's stock
DexCom raises 2026 revenue guidance midpoint
DexCom posted Q2 financial results that beat expectations, driven by strong sales of its continuous glucose monitors.
The company now expects 2026 revenue of $5.18B-$5.25B, up from its previous forecast.
DexCom’s stock rose ~7% in after-hours trading following the announcement.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
